Editor’s note: The stem cell world has been rich with conferences in the past week or so. I hope to have very brief notes on Cold Spring Harbor Laboratory and Stanford’s interdisciplinary program on stem cell policy over the next few days. For the recent World Stem Cell Conference in Baltimore, please check for Elie Dolgin’s posts in In the Field. Read more
Transplants of a fetal neural stem cell product seem safe, according to a 12-month study on six children with a horrible neurodegenerative disease called neuronal ceroid lipofuscinosis or Batten disease. Furthermore, the company reported results from an autopsy of a treated patient who died from the disease. (See Girl dies in stem cell trial for Batten disease ). These indicate that the injected cells engraft and survive in the brain for close to a year. Read more
Here’s a trio of three early stage studies that look encouraging for using stem cells as therapies in the brain. Read more
About this blog
The Niche is a blog hosted by Nature Reports Stem Cells to provide an informal forum for debate and commentary on stem cell research and its wider implications for ethics, policy, business, and medicine.